461 - 470 of 6422 Results
Title
Year
- Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort2022OPENTitle: Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohortJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-022-00964-1Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-022-00964-1Citation Count: 33
-
OPENTitle: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-32944-3Best OA location URL: https://www.nature.com/articles/s41467-022-32944-3.pdfCitation Count: 43
-
OPENTitle: Interpretable deep learning of myelin histopathology in age-related cognitive impairmentJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01425-5Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01425-5Citation Count: 28
- Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity2022OPENTitle: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicityJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 9Start Page: 1134End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01140-3Best OA location URL: https://www.nature.com/articles/s41593-022-01140-3.pdfCitation Count: 172
-
OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://doi.org/10.3389/fneur.2022.994114Citation Count: 4
- Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease2021OPENTitle: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2969End Page: 2971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28799Best OA location URL: https://doi.org/10.1002/mds.28799Citation Count: 14
-
OPENTitle: Adenosine A2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 853End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28897Best OA location URL: https://doi.org/10.1002/mds.28897Citation Count: 19
- Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment2022OPENTitle: Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive ImpairmentJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 713End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28913Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28913Citation Count: 61
-
OPENTitle: The Myelin‐Weighted Connectome in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 724End Page: 733Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28891Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28891Citation Count: 33
-
OPENTitle: A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1088End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28970Best OA location URL: https://doi.org/10.1002/mds.28970Citation Count: 31